Swiss National Bank’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Sell |
64,600
-7,300
| -10% | -$202K | ﹤0.01% | 1866 |
|
|
2025
Q1 | $1.6M | Hold |
71,900
| – | – | ﹤0.01% | 1892 |
|
|
2024
Q4 | $1.42M | Sell |
71,900
-6,700
| -9% | -$133K | ﹤0.01% | 2047 |
|
|
2024
Q3 | $1.96M | Hold |
78,600
| – | – | ﹤0.01% | 1870 |
|
|
2024
Q2 | $1.47M | Buy |
78,600
+23,000
| +41% | +$429K | ﹤0.01% | 1970 |
|
|
2024
Q1 | $1.1M | Hold |
55,600
| – | – | ﹤0.01% | 2172 |
|
|
2023
Q4 | $975K | Sell |
55,600
-5,100
| -8% | -$89.5K | ﹤0.01% | 2253 |
|
|
2023
Q3 | $1.05M | Hold |
60,700
| – | – | ﹤0.01% | 2218 |
|
|
2023
Q2 | $855K | Sell |
60,700
-6,400
| -10% | -$90.1K | ﹤0.01% | 2376 |
|
|
2023
Q1 | $722K | Sell |
67,100
-7,800
| -10% | -$83.9K | ﹤0.01% | 2407 |
|
|
2022
Q4 | $1.12M | Buy |
74,900
+2,600
| +4% | +$38.9K | ﹤0.01% | 2283 |
|
|
2022
Q3 | $928K | Hold |
72,300
| – | – | ﹤0.01% | 2377 |
|
|
2022
Q2 | $701K | Buy |
72,300
+12,200
| +20% | +$118K | ﹤0.01% | 2521 |
|
|
2022
Q1 | $597K | Buy |
60,100
+7,300
| +14% | +$72.5K | ﹤0.01% | 2559 |
|
|
2021
Q4 | $621K | Hold |
52,800
| – | – | ﹤0.01% | 2618 |
|
|
2021
Q3 | $601K | Hold |
52,800
| – | – | ﹤0.01% | 2560 |
|
|
2021
Q2 | $736K | Sell |
52,800
-1,400
| -3% | -$19.5K | ﹤0.01% | 2567 |
|
|
2021
Q1 | $1M | Buy |
54,200
+1,700
| +3% | +$31.5K | ﹤0.01% | 2343 |
|
|
2020
Q4 | $928K | Hold |
52,500
| – | – | ﹤0.01% | 2331 |
|
|
2020
Q3 | $804K | Buy |
52,500
+13,900
| +36% | +$213K | ﹤0.01% | 2207 |
|
|
2020
Q2 | $984K | Buy |
+38,600
| New | +$984K | ﹤0.01% | 2109 |
|
|
2019
Q4 | – | Sell |
-19,500
| Closed | -$166K | – | 2523 |
|
|
2019
Q3 | $166K | Hold |
19,500
| – | – | ﹤0.01% | 2506 |
|
|
2019
Q2 | $264K | Buy |
+19,500
| New | +$264K | ﹤0.01% | 2525 |
|